Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910879 · ClinicalTrials.gov registry record · NA
RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos)
A NA study of Health Behavior and Health Care Utilization, sponsored by University of Oregon.
- Active
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT05910879: Active NA study of Health Behavior and Health Care Utilization, sponsored by University of Oregon.
NCT05910879 is a NA study of Health Behavior and Health Care Utilization that is active but no longer recruiting, run by University of Oregon. The registered enrollment target is 600 participants, below the 2,177-participant average among 65 other Health Behavior trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05910879, a NA study of Health Behavior and Health Care Utilization, is active but no longer recruiting, sponsored by University of Oregon.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The ongoing Oregon Saludable: Juntos Podemos (OSJP, Healthy Oregon: Together We Can) project was developed to directly address the COVID-19 related health disparities among Latinx communities through community engagement funded by Phase I and II of the RADx-UP initiative. This project is organized by the University of Oregon's Oregon Saludable: Juntos Podemos (OSJP) project. In this Phase III study, study investigators build on the successful Phase I and Phase II partnerships with Latinx-serving community-based organizations and the project's established Community Scientific Advisory Board (CSAB) to employ a data-informed approach for implementing preventive interventions designed to advance health equity and ameliorate health disparities among vulnerable populations. Based on identity-stress and stereotype threat models for racial and ethnic minorities, study investigators will further tailor the Promotores de Salud COVID-19 evidence-based health promotion intervention to experimentally evaluate a brief behavioral self-affirming implementation intention (SAII) intervention; an approach that is evidence-based for increasing acceptance of health messaging, increasing intentions to change, increasing health promoting behaviors, and decreasing psychological distress. In collaboration with the Mexican Consulate (MC), research team members will attend the MC mobile events, invite MC attendees to participate in the research study and complete a survey, offer the Promotores de Salud, and SAII intervention to all attendees (if event is assigned to the intervention condition), and distribute rapid tests to participants.
Primary Outcome
Participants are offered to take home 0-4 SARS-CoV-2 rapid home test kits after enrolling in the project. The primary hypothesis focuses on increasing the likelihood a participant will take home testing kits for COVID-19. After the Promotores only intervention or the Promotores plus SAII intervention, the number or test kits participants choose to take home are recorded.
Conditions Studied
Interventions
- BEHAVIORAL Self-Affirmation Implementation Intentions (SAII) Intervention
- BEHAVIORAL Promotores de Salud (Health Education)
Study Locations (1)
Oregon
- University of Oregon - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2023-04-22 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the registry record for NCT05910879 still lists
NCT05910879 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 2,177-participant average among 65 other Health Behavior trials with a reported enrollment target (72% lower).
The record links to 3 conditions, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which Self-Affirmation Implementation Intentions (SAII) Intervention is the first listed.
NCT05910879 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05910879 about?
NCT05910879 is a clinical study titled "RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos)". The ongoing Oregon Saludable: Juntos Podemos (OSJP, Healthy Oregon: Together We Can) project was developed to directly address the COVID-19 related health disparities among Latinx communities through community engagement funded by Phase I and II of the RADx-UP initiative. This project is organized b...
What is the current status of trial NCT05910879?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2023-04-22. Estimated completion is 2024-12-31.
What conditions does trial NCT05910879 study?
This clinical trial studies the following conditions: Health Behavior, Health Care Utilization, Vaccine Hesitancy.
What interventions are being tested in trial NCT05910879?
The interventions under investigation include: Self-Affirmation Implementation Intentions (SAII) Intervention (BEHAVIORAL), Promotores de Salud (Health Education) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05910879?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05910879 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05910879's enrollment target sits among peer trials
600 17th of 65 higher than 49 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI